Sahlgrenska University Hospital selects C-RAD’s innovative SIGRT solution

C-RAD announced today an order for its advanced surface tracking technology from Sahlgrenska University Hospital in Gothenburg, Sweden. The customer decided to equip the newly ordered linear accelerators with Catalyst HD™ and upgrades the existing C-RAD installation to its latest version.

With a capacity of in total eleven linear accelerators and two more treatment rooms under construction Sahlgrenska University Hospital together with the satellite center in Borås is the largest radiation therapy department in Sweden and one of the leading academic medical centers. As part of the tender the customer secured an option to equip all remaining linear accelerators with C-RAD technology.

The Catalyst HD™ system will be delivered with the complete software suite for DIBH (Deep Inspiration Breath Hold) and SRT (Stereotactic Radiation Therapy). The C-RAD SIGRT solution is packaged with modules for patient positioning, respiratory gating and motion monitoring during treatment. C-RAD provides interfaces to seamlessly integrate its products into the workflow, for a maximum in user comfort and patient safety.

The order amounts to a total of approximately 8,5 MSEK. It includes beside the C-RAD SIGRT systems a minor part of dosimetry products that C-RAD is distributing in Sweden. It is expected to commence delivery for the first system in the fourth quarter 2018. The project is booked as order intake in the third quarter 2018.

"The cooperation between C-RAD and the team at Sahlgrenska University Hospital has been excellent over the years. With the new procurement the cooperation gets even closer and ultimately, together we will be able to provide an increasing number of patients access to treatments supported by C-RAD’s cutting-edge technology.” says Tim Thurn, CEO and President of C-RAD AB, "We are proud to be part of the journey to improve cancer care in Sweden and worldwide.”

About C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on Nasdaq Stockholm.
For more information on C-RAD, please visit http://www.c-rad.com

For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com

This information is information that C-RAD AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 15:30 CEST on September 27, 2018.

Attachment

• PR 20180927 Order Sahlgrenska ENG